These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 29779047

  • 1. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
    Stenman A, Zedenius J, Juhlin CC.
    Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
    [Abstract] [Full Text] [Related]

  • 2. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
    Wachtel H, Hutchens T, Baraban E, Schwartz LE, Montone K, Baloch Z, LiVolsi V, Krumeich L, Fraker DL, Nathanson KL, Cohen DL, Fishbein L.
    J Clin Endocrinol Metab; 2020 Dec 01; 105(12):e4661-70. PubMed ID: 32877928
    [Abstract] [Full Text] [Related]

  • 3. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.
    Koh JM, Ahn SH, Kim H, Kim BJ, Sung TY, Kim YH, Hong SJ, Song DE, Lee SH.
    PLoS One; 2017 Dec 01; 12(11):e0187398. PubMed ID: 29117221
    [Abstract] [Full Text] [Related]

  • 4. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
    Rajan S, Zaidi G, Agarwal G, Mishra A, Agarwal A, Mishra SK, Bhatia E.
    World J Surg; 2016 Mar 01; 40(3):690-6. PubMed ID: 26438242
    [Abstract] [Full Text] [Related]

  • 5. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
    Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M, Ghossein RA.
    Surgery; 2008 Jun 01; 143(6):759-68. PubMed ID: 18549892
    [Abstract] [Full Text] [Related]

  • 6. Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior.
    Stenman A, Svahn F, Hojjat-Farsangi M, Zedenius J, Söderkvist P, Gimm O, Larsson C, Juhlin CC.
    Am J Surg Pathol; 2019 Mar 01; 43(3):409-421. PubMed ID: 30451732
    [Abstract] [Full Text] [Related]

  • 7. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates.
    Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ.
    J Pathol; 2000 Oct 01; 192(2):221-8. PubMed ID: 11004699
    [Abstract] [Full Text] [Related]

  • 8. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
    van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW, van de Meiracker AH, Boomsma F, Stijnen T, Krenning EP, Bosman FT, Kwekkeboom DJ.
    J Clin Endocrinol Metab; 2001 Feb 01; 86(2):685-93. PubMed ID: 11158032
    [Abstract] [Full Text] [Related]

  • 9. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
    Guo Z, Lloyd RV.
    Adv Anat Pathol; 2015 Sep 01; 22(5):283-93. PubMed ID: 26262510
    [Abstract] [Full Text] [Related]

  • 10. The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature.
    Stenman A, Zedenius J, Juhlin CC.
    Cancers (Basel); 2019 Feb 15; 11(2):. PubMed ID: 30769931
    [Abstract] [Full Text] [Related]

  • 11. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
    Juhlin CC.
    Endocr Pathol; 2021 Jun 15; 32(2):228-244. PubMed ID: 33768452
    [Abstract] [Full Text] [Related]

  • 12. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
    Korpershoek E, Van Nederveen FH, Dannenberg H, Petri BJ, Komminoth P, Perren A, Lenders JW, Verhofstad AA, De Herder WW, De Krijger RR, Dinjens WN.
    Ann N Y Acad Sci; 2006 Aug 15; 1073():138-48. PubMed ID: 17102080
    [Abstract] [Full Text] [Related]

  • 13. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
    Breza J, Breza J.
    Bratisl Lek Listy; 2018 Aug 15; 119(2):120-125. PubMed ID: 29455549
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
    Stenman A, Svahn F, Welander J, Gustavson B, Söderkvist P, Gimm O, Juhlin CC.
    Endocr Pathol; 2015 Mar 15; 26(1):9-14. PubMed ID: 25403449
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of morphology of adrenal pheochromocytoma as regards their potential malignancy].
    Kajor M, Ziaja J, Lange D, Król R, Ciupińska-Kajor M, Turska-d'Amico M, Maka B, Cierpka L.
    Endokrynol Pol; 2005 Mar 15; 56(6):911-6. PubMed ID: 16821210
    [Abstract] [Full Text] [Related]

  • 16. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
    Stenman A, Zedenius J, Juhlin CC.
    Surgery; 2019 Nov 15; 166(5):901-906. PubMed ID: 31239074
    [Abstract] [Full Text] [Related]

  • 17. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
    Ospina NS, Maraka S, Donegan D, Morris JC.
    Thyroid; 2017 Oct 15; 27(10):1332-1334. PubMed ID: 28747092
    [Abstract] [Full Text] [Related]

  • 18. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
    Quayle FJ, Fialkowski EA, Benveniste R, Moley JF.
    Surgery; 2007 Dec 15; 142(6):800-5; discussion 805.e1. PubMed ID: 18063059
    [Abstract] [Full Text] [Related]

  • 19. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM.
    Thyroid; 2011 Sep 15; 21(9):975-85. PubMed ID: 21834681
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW, Brouwers FM, Lubensky IA, Vortmeyer AO, Weil RJ, Walther MM, Oldfield EH, Linehan WM, Pacak K, Zhuang Z.
    J Clin Endocrinol Metab; 2005 Jun 15; 90(6):3747-51. PubMed ID: 15769989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.